Posts Tagged ‘GvHD’

The story of the first bone marrow transplant

Author: Jovana Drinjakovic, 09/15/16

It was a failed transplant that saved his life. In 1958, Radojko Maksic became the first person to receive a bone marrow graft from a stranger, after he was accidentally exposed to a lethal dose of radiation in Belgrade, in what was then Yugoslavia. He still lives in Belgrade, almost 60 years after the procedure….Read more

Update from the Clinic: January

Author: Mark Curtis, 02/22/16

Welcome to your update from the clinic for the month of January. It was a quiet month in the clinic. However, we did see some clearances for various clinical studies, including Fate’s ProTmune in GvHD and Pluristem’s PLX-R18 in hematopoietic recovery following bone marrow transplant. Pluristem (PSTM) continues to increase the breadth of applications for…Read more

Cells as drugs: Health Canada approves mesenchymal stem cell based treatment

Author: Paul Krzyzanowski, 05/22/12

Many readers may already have heard of Health Canada’s approval of Osiris’ Prochymal, a mesenchymal stem cell treatment for severe cases of pediatric Graft versus Host Disease (GvHD), with plenty of coverage circulating around the web. GvHD is a disease where transplanted bone marrow generates an immune system that attacks cells of the recipient.  The…Read more